<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7678976</article-id><article-id pub-id-type="pmc">1968228</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jones</surname><given-names>A. S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Phillips</surname><given-names>D. E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cook</surname><given-names>J. A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Helliwell</surname><given-names>T. R.</given-names></name></contrib></contrib-group><aff>Department of Otorhinolaryngology, University of Liverpool, UK.</aff><pub-date pub-type="ppub"><month>1</month><year>1993</year></pub-date><volume>67</volume><issue>1</issue><fpage>112</fpage><lpage>114</lpage><abstract><p>Sixteen patients with advanced and recurrent malignant salivary gland tumours were admitted to a randomised trial and the response assessed. Seven patients received Epirubicin/5-Fluorouracil and none of these patients responded. Nine patients received Cisplatinum and only one patient had a partial response. The trial suggests that chemotherapy has no place in the treatment of advanced salivary gland malignant tumours.</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00203-0122.tif" xlink:title="scanned-page" xlink:role="112" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00203-0123.tif" xlink:title="scanned-page" xlink:role="113" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00203-0124.tif" xlink:title="scanned-page" xlink:role="114" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

